Skip to main content
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
TA-TMA: state of the art for diagnosis and treatment.
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Paroxysmal cold hemoglobinuria successfully treated with complement inhibition.
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Related and unrelated donor transplantation for ß-thalassemia major: results of an international survey.